Skip to content

Pharmagreen Biotech Inc.

company.status.inactive

CIK 1435181fmd_0WTJHAFBKCF9CQGYKDC8R144B7Transportation, Communications, Electric, Gas and Sanitary Services · Airports, Flying Fields & Airport Terminal ServicesTemplate: Standard

Coverage: Oct 01, 2017 to Jun 30, 2023, 21 periods

Latest annual · FY2022

Millions
Operating income
(1)
Net income
(1)

Latest quarter · Q3 FY2023

Millions
Total revenues
0
Gross profit
0
Operating income
(0)
Net income
(0)
Open Financials

Pharmagreen Biotech Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Operating income-$1.1 million-$744,06410-K 2023-01-17 · proof
Net income-$875,505-$4.5 million10-K 2023-01-17 · proof
Cash from operating activities-$426,568-$206,08110-K 2023-01-17 · proof
Total assets$208,971$373,081-44%10-K 2023-01-17 · proof
Total liabilities$2 million$2.1 million-1.7%10-K 2023-01-17 · proof
Cash and cash equivalents$8,016$25,300-68.3%10-K 2023-01-17 · proof
What was Pharmagreen Biotech Inc.'s operating income in fiscal 2022?
Pharmagreen Biotech Inc. reported operating income of -$1.1 million for fiscal 2022 (the year ended Sep 30, 2022), against -$744,064 the year before. Source: the 10-K filed with the SEC on Jan 17, 2023. SEC
What was Pharmagreen Biotech Inc.'s net income in fiscal 2022?
Pharmagreen Biotech Inc. reported net income of -$875,505 for fiscal 2022 (the year ended Sep 30, 2022), against -$4.5 million the year before. Source: the 10-K filed with the SEC on Jan 17, 2023. SEC
What was Pharmagreen Biotech Inc.'s cash from operating activities in fiscal 2022?
Pharmagreen Biotech Inc. reported cash from operating activities of -$426,568 for fiscal 2022 (the year ended Sep 30, 2022), against -$206,081 the year before. Source: the 10-K filed with the SEC on Jan 17, 2023. SEC
What are Pharmagreen Biotech Inc.'s total assets?
As of Sep 30, 2022, Pharmagreen Biotech Inc. reported total assets of $208,971, against $373,081 a year earlier (-44%). Source: the 10-K filed with the SEC on Jan 17, 2023. SEC
What are Pharmagreen Biotech Inc.'s total liabilities?
As of Sep 30, 2022, Pharmagreen Biotech Inc. reported total liabilities of $2 million, against $2.1 million a year earlier (-1.7%). Source: the 10-K filed with the SEC on Jan 17, 2023. SEC
What are Pharmagreen Biotech Inc.'s cash and cash equivalents?
As of Sep 30, 2022, Pharmagreen Biotech Inc. reported cash and cash equivalents of $8,016, against $25,300 a year earlier (-68.3%). Source: the 10-K filed with the SEC on Jan 17, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1435181&period_type=annual&limit=5"

Information only, not investment advice.